Literature DB >> 14729580

Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk.

Rayjean J Hung1, Paolo Boffetta, Paul Brennan, Christian Malaveille, Umberto Gelatti, Donatella Placidi, Angela Carta, Agnès Hautefeuille, Stefano Porru.   

Abstract

Tobacco smoking and occupational exposure are major risk factors of bladder cancer via exposure to polycyclic aromatic hydrocarbons (PAHs) and aromatic amines, which lead to oxidative stress and DNA damage. Several enzymes, which play key roles in oxidative stress are polymorphic in humans. Myeloperoxidase (MPO) produces a strong oxidant for microbicidal activity, and activates carcinogens in tobacco smoke. Catechol-O-methyltransferase (COMT) catalyzes the methylation of endo- and xenobiotics and prevents redox cycling. NAD(P)H:quinone oxidoreductase (NQO1) catalyzes the two-electron reduction of quinoid compounds, which also protects cells from redox cycling. Manganese superoxide dismutase (MnSOD) protects cells from free radical injury. To test the hypothesis that the risk of bladder cancer can be influenced by polymorphisms in the genes that modulate oxidative stress, in particular by interacting with environmental carcinogens, we conducted a hospital-based case-control study among men in Brescia, Northern Italy. We recruited and interviewed 201 incident cases and 214 controls from 1997 to 2000. Occupational exposures to PAHs and aromatic amines were coded blindly by occupational physicians. Unconditional multivariate logistic regression was applied to model the association between genetic polymorphisms and bladder cancer risk and the effect of modifications of smoking and occupational exposures were evaluated. MPO G-463A homozygous variant was associated with a reduced risk of bladder cancer with an OR of 0.31 (95% CI = 0.12-0.80). MnSOD Val/Val genotype increased the risk of bladder cancer with OR of 1.91 (95% CI = 1.20-3.04), and there was a combined effect with smoking (OR = 7.20, 95% CI = 3.23-16.1) and PAH (OR = 3.02, 95% CI = 1.35-6.74). We did not observe an effect of COMT Val108Met polymorphism. These findings suggest that individual susceptibility of bladder cancer may be modulated by MPO and MnSOD polymorphisms, and that the combination of genetic factors involved in oxidative stress response with environmental carcinogens may play an important role in bladder carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14729580     DOI: 10.1093/carcin/bgh080

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  62 in total

1.  The utility of naphthyl-keratin adducts as biomarkers for jet-fuel exposure.

Authors:  Juei-Chuan C Kang-Sickel; Mary Ann Butler; Lynn Frame; Berrin Serdar; Yi-Chun E Chao; Peter Egeghy; Stephen M Rappaport; Christine A Toennis; Wang Li; Tatyana Borisova; John E French; Leena A Nylander-French
Journal:  Biomarkers       Date:  2011-09-30       Impact factor: 2.658

Review 2.  Superoxide dismutase 2 gene and cancer risk: evidence from an updated meta-analysis.

Authors:  Sang Wook Kang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Association of smoking with dsDNA autoantibody production in systemic lupus erythematosus.

Authors:  M M Freemer; T E King; L A Criswell
Journal:  Ann Rheum Dis       Date:  2005-09-08       Impact factor: 19.103

4.  Mn-SOD and CuZn-SOD polymorphisms and interactions with risk factors in gastric cancer.

Authors:  Jian-Feng Yi; Yu-Min Li; Tao Liu; Wen-Ting He; Xun Li; Wen-Ce Zhou; Shi-Liang Kang; Xiang-Ting Zeng; Jun-Qiang Zhang
Journal:  World J Gastroenterol       Date:  2010-10-07       Impact factor: 5.742

5.  Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues.

Authors:  Andrew D Johnson; Ying Zhang; Audrey C Papp; Julia K Pinsonneault; Jeong-Eun Lim; David Saffen; Zunyan Dai; Danxin Wang; Wolfgang Sadée
Journal:  Pharmacogenet Genomics       Date:  2008-09       Impact factor: 2.089

6.  Association between ITGA2 C807T polymorphism and gastric cancer risk.

Authors:  Jie Chen; Nan-Nan Liu; Jia-Qi Li; Li Yang; Ying Zeng; Xiao-Mei Zhao; Lin-Lin Xu; Xuan Luo; Bin Wang; Xue-Rong Wang
Journal:  World J Gastroenterol       Date:  2011-06-21       Impact factor: 5.742

7.  Association of microRNA-196a-2 gene polymorphism with gastric cancer risk in a Chinese population.

Authors:  Sheng Peng; Zhongshen Kuang; Chenyi Sheng; Yan Zhang; Hang Xu; Qinghong Cheng
Journal:  Dig Dis Sci       Date:  2009-10-16       Impact factor: 3.199

8.  A prospective study of genetic polymorphism in MPO, antioxidant status, and breast cancer risk.

Authors:  Chunyan He; Rulla M Tamimi; Susan E Hankinson; David J Hunter; Jiali Han
Journal:  Breast Cancer Res Treat       Date:  2008-03-14       Impact factor: 4.872

9.  Genetic Polymorphisms of CYP2E1, GSTP1, NQO1 and MPO and the Risk of Nasopharyngeal Carcinoma in a Han Chinese Population of Southern China.

Authors:  Xiuchan Guo; Yi Zeng; Hong Deng; Jian Liao; Yuming Zheng; Ji Li; Bailey Kessing; Stephen J O'Brien
Journal:  BMC Res Notes       Date:  2010-07-27

10.  Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort.

Authors:  Ji-Yeob Choi; Marian L Neuhouser; Matt J Barnett; Chi-Chen Hong; Alan R Kristal; Mark D Thornquist; Irena B King; Gary E Goodman; Christine B Ambrosone
Journal:  Carcinogenesis       Date:  2008-02-22       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.